Skip to main navigation
  • About
    • About Us
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • Hepatitis C Virus
    • Hepatitis B Virus
    • Respiratory Syncytial Virus
    • SARS-CoV-2
    • Human Metapneumovirus
  • Science
    • Overview
    • Publications
  • Patients
    • Overview
    • Clinical Trials
    • Resources
  • Careers
    • Join Us
    • Culture
    • Core Values
    • Testimonials
    • Benefits
  • Collaborations
    • Partnering
    • Out-Licensing
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • RSS Feeds
  • Contact Us

Press Releases

  • Overview
  • Press Releases
  • Events & Presentations
  • Stock Information
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Financials
    • Quarterly Results
    • Annual Reports
    • SEC Filings
  • Corporate Governance
    • Documents & Charters
    • Board of Directors
    • Management Team
    • Committee Composition
  • Investor Resources
    • Investor FAQs
    • Email Alerts
    • RSS Feeds
Date Title
January 6, 2022 Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and Outlook for 2022 at the 40th Annual J.P. Morgan Healthcare Conference
January 4, 2022 Enanta Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Current page 2
Displaying 11 - 12 of 12
  • Print Page Print Page
  • Email Alerts Email Alerts
  • RSS Feeds RSS Feeds
  • Contact IR Contact IR
enanta logo

©2022 Enanta Pharmaceuticals, Inc.

ENANTA PHARMACEUTICALS and accompanying logos are trademarks or registered trademarks of Enanta Pharmaceuticals, Inc.

Explore

  • About
  • Pipeline
  • Science
  • Patients
  • Careers
  • Collaborations
  • Investors
  • Contact Us

Contact

Enanta Pharmaceuticals, Inc. Headquarters
500 Arsenal Street
Watertown, MA 02472

(617) 607-0800
info@enanta.com

Legal

  • Privacy Policy
  • Twitter Policy
  • Terms of Use
social media iconTwitter social media iconLinkedin
MENU
  • About
    • About Us
    • Management Team
    • Board of Directors
  • Pipeline
    • Overview
    • Hepatitis C Virus
    • Hepatitis B Virus
    • Respiratory Syncytial Virus
    • SARS-CoV-2
    • Human Metapneumovirus
  • Science
    • Overview
    • Publications
  • Patients
    • Overview
    • Clinical Trials
    • Resources
  • Careers
    • Join Us
    • Culture
    • Core Values
    • Testimonials
    • Benefits
  • Collaborations
    • Partnering
    • Out-Licensing
  • Investors
    • Overview
    • Press Releases
    • Events & Presentations
    • Stock Information
      • Stock Quote & Chart
      • Historic Price Lookup
      • Investment Calculator
      • Analyst Coverage
    • Financials
      • Quarterly Results
      • Annual Reports
      • SEC Filings
    • Corporate Governance
      • Documents & Charters
      • Board of Directors
      • Management Team
      • Committee Composition
    • Investor Resources
      • Investor FAQs
      • Email Alerts
      • RSS Feeds
  • Contact Us